![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 30, 21313-21318, July 23, 1999
From the Department of Cell Biology and Physiology, Washington
University School of Medicine, St. Louis, Missouri 63110
SNAP-25, syntaxin, and synaptobrevin are SNARE
proteins that mediate fusion of synaptic vesicles with the plasma
membrane. Membrane attachment of syntaxin and synaptobrevin is achieved through a C-terminal hydrophobic tail, whereas SNAP-25 association with
membranes appears to depend upon palmitoylation of cysteine residues
located in the center of the molecule. This process requires an intact
secretory pathway and is inhibited by brefeldin A. Here we show that
the minimal plasma membrane-targeting domain of SNAP-25 maps to
residues 85-120. This sequence is both necessary and sufficient to
target a heterologous protein to the plasma membrane. Palmitoylation of
this domain is sensitive to brefeldin A, suggesting that it uses the
same membrane-targeting mechanism as the full-length protein. As
expected, the palmitoylated cysteine cluster is present within this
domain, but surprisingly, membrane anchoring requires an additional
five-amino acid sequence that is highly conserved among SNAP-25 family
members. Significantly, the membrane-targeting module coincides with
the protease-sensitive stretch (residues 83-120) that connects the two
Intracellular membrane trafficking depends on specific
interactions between vesicles and target membranes. Biochemical and genetic studies demonstrate that integral membrane proteins referred to
as SNAREs (soluble
N-ethylmaleimide-sensitive factor attachment protein receptors) are important
elements in this process (1, 2). The best characterized SNARE proteins
are those that mediate synaptic vesicle exocytosis in nerve terminals
(reviewed in Ref. 3). SNAP-25
(synaptosome-associated
protein of 25 kDa) and syntaxin are plasma
membrane proteins that bind to the synaptic vesicle protein,
synaptobrevin/vesicle-associated membrane protein. The critical role
that these proteins play in neurotransmission is underscored by the
fact that all three are targets of tetanus or botulinum neurotoxins
that block neurotransmitter release.
SNAP-25, syntaxin, and synaptobrevin bind to each other to form a
stable heterotrimeric complex that consists of a four-helix bundle (4,
5). SNAP-25 contributes two helices from its N- and C-terminal domains;
syntaxin and synaptobrevin each provide one. Syntaxin and synaptobrevin
are anchored in opposing membranes through transmembrane domains at
their C termini. The parallel orientation of these membrane-anchored
helices within the complex has led to a model in which the zippering
action of complex formation brings the membranes together, with the
energy of complex formation driving membrane fusion (6-8). However,
whether SNARE proteins directly mediate fusion remains uncertain
(9).
Unlike synaptobrevin and syntaxin, SNAP-25 is associated with membranes
through palmitoylated cysteines found near the center of the molecule
(10). The cysteine-rich sequence is contained within the linker between
the N- and C-terminal helices that SNAP-25 contributes to the core
synaptic fusion complex (4). The structure of the linker domain is
unknown, but is presumed to be exposed and disordered in the complex
in vitro because of its susceptibility to proteolytic
cleavage (11, 12). In any case, this region of SNAP-25 has to be
sufficiently extended to accommodate the parallel orientation of both
SNAP-25 helices in the synaptic fusion complex (4).
Palmitoylation is one of several lipid modifications that otherwise
soluble polypeptides use to associate with the cytoplasmic face of
intracellular membranes (reviewed in Ref. 13). SNAP-25, GAP-43
(growth-associated protein of
43 kDa), and cysteine string protein are examples of
proteins modified by thioester-linked palmitate at multiple cysteine
residues. Other proteins located at the plasma membrane are modified
sequentially with two different lipid moieties. These include many
non-receptor tyrosine kinases and G-protein The role that different lipid moieties play in the trafficking of newly
synthesized proteins to their resident membranes is beginning to be
defined. Dual lipidation by myristoylation and palmitoylation appears
to confer rapid targeting of p59fyn, a non-receptor tyrosine
kinase, to the plasma membrane, whereas modification with palmitate
alone is associated with slower kinetics of membrane association of
GAP-43 and SNAP-25 (14, 15). We demonstrated previously in neuronal
cell lines that palmitoylation of SNAP-25 and GAP-43, but not
Go Lipidated proteins are typically modified near their N or C termini.
SNAP-25 is unusual in this regard with its centrally located cysteine
cluster. This motif is distinct from the N-terminal palmitoylation
motifs found on other neuronal proteins such as GAP-43 and SCG-10. The
first 35 amino acids of SCG-10, which include the palmitoylated
cysteines at positions 22 and 24, contain the membrane-targeting
information (16). Membrane association of GAP-43 is dependent upon
palmitoylated cysteines at positions 3 and 4 (17). Previous studies
have demonstrated that the palmitoylated cysteines are necessary for
membrane association of SNAP-25 (18, 19). However, it has not been
determined whether the cysteine-rich domain is sufficient to confer
plasma membrane localization. Indeed, we have suggested previously that
SNAP-25 may bind to syntaxin (or another protein) to facilitate the
subsequent interaction of SNAP-25 with a palmitoyltransferase (15). In
this study, we sought to define and characterize the plasma
membrane-targeting domain of SNAP-25. Using a deletion and mutagenesis
strategy, we mapped the minimal region of SNAP-25 required for membrane localization to a centrally located 35-amino acid sequence. In addition
to the palmitoylated cysteines, plasma membrane localization of SNAP-25
also requires a novel five-amino acid motif at the C terminus of this
membrane-targeting domain.
Construction of SNAP-25/GFP Fusion Plasmids--
The SNAP-25/GFP
constructs discussed in this paper are summarized in Fig. 1. Standard
molecular cloning techniques were used to manipulate DNA (20). The
integrity of all constructs derived from PCR products was verified by
DNA sequence analysis. Plasmids pEGFP-N and pEGFP-C, which fuse the GFP
coding region to the 3'- or 5'-end of the inserted sequence,
respectively, were purchased from CLONTECH (Palo
Alto, CA). Dr. Michael C. Wilson (University of New Mexico) kindly
provided the SNAP-25b cDNA. Full-length SNAP-25 was inserted into
pEGFP-C as a KpnI/BamHI fragment (GFP/1-206). 1-142/GFP was first introduced into pEGFP-N as a
KpnI/SmaI fragment. To eliminate the
5'-untranslated region in 1-142/GFP, we generated a 5'-oligonucleotide
that introduces a XhoI site and anneals to the first 18 bases of the SNAP-25 open reading frame. The PCR product encoding
residues 1-142 of SNAP-25 was introduced into pEGFP-N as a
XhoI/SmaI fragment. PCR products encoding
residues 1-115 and 1-120 of SNAP-25 were cloned into pEGFP-N as
XhoI/BamHI fragments. SNAP-25 residues 45-142
and 56-142 were inserted into pEGFP-N as
XhoI/SmaI fragments. The constructs 56-95/GFP
and 1-95/GFP were generated using a 3'-reverse oligonucleotide
annealing across the unique HindIII site of the SNAP-25
coding region and 5'-oligonucleotides annealing at appropriate start
sites. The PCR products were then introduced into pEGFP-N as
BglII/HindIII (56-95/GFP) and
XhoI/HindIII (1-95/GFP) fragments. The PCR
product encoding residues 85-120 was cloned into pEGFP-N as a
XhoI/BamHI fragment. An in-frame ATG codon was
included in the 5'-oligonucleotide primers for SNAP-25 constructs with
N-terminal deletions.
To replace all four cysteine residues with alanines in 1-142/GFP, a
two-step construction was used. First, residues 85 and 88 were mutated
using a PCR-based strategy. A PCR product was generated using a
5'-oligonucleotide corresponding to the first 18 bases of the SNAP-25
open reading frame and a mutant 3'-reverse oligonucleotide that
annealed across the unique HindIII site of the SNAP-25
coding sequence. The plasmid 1-142/GFP was digested with
HindIII and XhoI to generate a vector containing
95-142/GFP. The C85-88A PCR fragment
(XhoI/HindIII) was ligated with the vector. The
resulting plasmid was used as template to mutate cysteine residues 90 and 92, using a similar strategy. Gln116,
Pro117, and Arg118 of SNAP-25 were mutated to
alanine in the context of the 85-120/GFP fusion using the Quikchange
mutagenesis kit (Stratagene, La Jolla, CA).
Transient Transfection of NG108 Cells--
NG108 cells were
cultured in high glucose Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum, 2 mM glutamine,
150 units/ml penicillin, and 50 µg/ml streptomycin. The cells were
grown in six-well or 35-mm tissue culture plates coated with
poly-L-lysine until 50-80% confluent. Cells were
transfected using LipofectAMINE reagent (Life Technologies, Inc.)
according to the manufacturer's instructions and analyzed 24 h later.
Confocal Laser Microscopy--
Twenty hours after transfection,
NG108 cells were washed with phosphate-buffered saline and fixed with
freshly prepared 4% (w/v) paraformaldehyde for 15 min at room
temperature. Subsequently, cells were washed with phosphate-buffered
saline, and coverslips were mounted on slides with a drop of
Vectashield mounting medium (Vector Laboratories, Inc., Burlingame,
CA). Cells were examined using a Zeiss Axioplan microscope coupled to
an MRC-1000 laser scanning confocal microscope (Bio-Rad) with a 63×
oil immersion objective. Confocal images were assembled as montages
using Adobe Photoshop Version 3.0 and Canvas 3.5
Radiolabeling, BFA Treatment, and Immunoprecipitation--
Cells
were radiolabeled with [35S]methionine and
[3H]palmitate for 90 min as described (15). Brefeldin A
suspended in dimethyl sulfoxide was added to the cells along with the
radiolabel (final concentration of 10 µg/ml). Control cells were
incubated with dimethyl sulfoxide alone. Cells were solubilized with
radioimmune precipitation assay buffer and processed for
immunoprecipitation as described (15). Lysates were immunoprecipitated
with rabbit anti-GFP polyclonal antibody
(CLONTECH). Radiolabeled polypeptides were detected
by fluorography. [35S]Methionine-labeled proteins were
detectable after 2 or 3 h, and [3H]palmitate-labeled
proteins after overnight exposure.
Subcellular Fractionation--
Cells growing in 100-mm dishes
were transfected with the appropriate constructs and, 16-20 h after
transfection, were washed with warm phosphate-buffered saline and
scraped into ice-cold phosphate-buffered saline. Cells were collected
by centrifugation and suspended in a hypotonic buffer (20 mM Tris-HCl, pH 7.4. 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl
fluoride, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 1 mM
benzamidine, and 10 µg/ml pepstatin). After a 15-min incubation,
cells were homogenized with 20 passes through a ball-bearing
homogenizer and pelleted at 800 × g for 5 min. The
pellet consisting of unbroken cells and nuclei was designated P1. The
post-nuclear supernatant was centrifuged at 100,000 × g for 30 min. The resulting supernatant (S100 fraction) was
mixed with an equivalent volume of 2× radioimmune precipitation assay
buffer. The 100,000 × g pellet (P100 fraction) was
solubilized by suspension in radioimmune precipitation assay buffer.
Equal fractions of P1, P100, and S100 were analyzed by immunoblotting.
GFP fusion proteins were detected with an anti-GFP monoclonal antibody
(CLONTECH) and 125I-labeled secondary
antibody (ICN, Costa Mesa, CA). Quantitation of the immunoblots was
performed using a PhosphorImager screen and ImageQuant software
(Molecular Dynamics, Inc.).
Full-length SNAP-25 Targets GFP to the Plasma
Membrane--
SNAP-25 is localized predominately at the plasma
membrane in neurons and neuronal cell lines (21, 22). To determine if GFP could be used as a reporter to characterize the membrane-targeting domain of SNAP-25, we constructed a fusion protein with full-length SNAP-25 fused to GFP (Fig. 1). This
construct was transiently transfected into NG108 cells, and its
localization was visualized by fluorescence microscopy. As shown in
Fig. 2A, GFP alone localized to the cytosol of NG108 cells. In contrast, the SNAP-25/GFP fusion was
localized at the plasma membrane and enriched in cellular processes. This pattern is very similar to that of endogenous protein and indicates that full-length SNAP-25 can direct GFP to the
plasma membrane. Immunoblot analysis confirmed that the fusion protein
was the appropriate molecular mass (Fig. 2B).
Residues 85-120 of SNAP-25 Target GFP to the Plasma
Membrane--
To identify the minimal plasma membrane-targeting
elements within SNAP-25, we constructed a series of deletion mutants of SNAP-25 fused to GFP (Fig. 1). SNAP-25 contains two sets of heptad repeats at the N terminus interrupted by a break in frame (residues 1-42 and 45-90) (23). A third set of heptad repeats is found in the
C-terminal region of the protein between residues 157 and 205. These
heptad repeats form
To further characterize the membrane-targeting domain of SNAP-25, we
constructed a truncated chimeric protein lacking the most N-terminal
set of heptad repeats (45-142/GFP) (H1 in Fig. 1). Based on
studies of in vitro binding reactions of SNAP-25 deletion
mutants with syntaxin, the loss of residues 1-44 should eliminate
SNAP-25 interactions with syntaxin (23). This fusion protein localized
to the plasma membrane of NG108 cells (Fig. 3c), indicating
that SNAP-25 can associate with membranes independently of interactions
with syntaxin.
Residues 45-142 of SNAP-25 include the amino acids encoded by the
alternatively spliced exon 5 of the gene (amino acids 56-95). The two
isoforms of SNAP-25 (a and b) differ at nine residues within this
region (24), and it has been proposed that these differences might
confer differential localization of the two isoforms (25). We tested
whether exon 5 encodes all of the membrane-targeting information by
fusing residues 56-95 to GFP. As shown in Fig. 3d,
sequences encoded by exon 5 were not sufficient to target GFP to
membranes. Extension of this region at the N terminus (1-95/GFP) did
not restore membrane localization (Fig. 3e). However,
extension of this region at the C terminus (56-142/GFP) resulted in an
appropriate plasma membrane distribution (Fig. 3f). Thus,
residues 1-55 were dispensable for targeting, but some residues
between positions 95 and 142 were required for plasma membrane localization.
To define the C-terminal boundary of the membrane-targeting domain of
SNAP-25, we made serial deletions inward from residue 142. The
constructs 1-115/GFP and 1-120/GFP revealed that the N-terminal 115 amino acids were not sufficient to target GFP to the plasma membrane
(Fig. 3g), but residues 1-120 were (Fig. 3h). Using residue 120 as the C-terminal boundary, we established the N-terminal boundary of the membrane-targeting domain by making sequential deletions from residues 56 to 85, the position of the first
palmitoylated cysteine. As shown in Fig. 3i, amino acids 85-120 of SNAP-25 were sufficient to target a heterologous protein to
the plasma membrane of NG108 cells. Interestingly, this sequence coincides almost exactly with the protease-sensitive interhelical domain (residues 83-120) of SNAP-25 in the SNARE complex (11, 12). All
of the deletion constructs were expressed at similar levels and
migrated at the predicted molecular mass as assessed by immunoblotting
(data not shown). The N-terminal boundary of the membrane-targeting
domain was defined as residue 85 because mutation of this site in the
context of the full-length protein (or in 1-142/GFP) results in a
significant decrease in membrane association and loss of radioactive
palmitate incorporation
(18).2
Palmitoylation of the Membrane-targeting Domain of SNAP-25 Is
Sensitive to BFA--
To investigate if the chimera 85-120/GFP
retains the ability to be palmitoylated, we incubated NG108 cells
expressing 85-120/GFP with [3H]palmitate and assayed for
incorporation of radiolabel into the immunoprecipitated protein. As
shown in Fig. 4, the 85-120/GFP protein
(lane 7) incorporated [3H]palmitate, as did
the GFP fusion with the full-length sequence of SNAP-25 (lane
3). Palmitoylation and membrane association of newly synthesized
endogenous SNAP-25 require an intact secretory pathway in neuronal cell
lines (PC12, N2A, and NG108 cells) (15). To determine if palmitoylation
of the membrane-targeting domain of SNAP-25 resembles that of
endogenous protein, we evaluated the sensitivity of this process to
BFA. As shown in Fig. 4, palmitoylation of both full-length SNAP-25
(lane 4) and the membrane-targeting domain (lane
8) was inhibited by BFA. The inhibitory effect of BFA on
palmitoylation was not due to decreased protein expression, as equal
amounts of [35S]methionine-labeled protein are found in
the immunoprecipitates in the presence or absence of drug (lanes
1, 2, 5, and 6). Our results
indicate that the post-translational processing of the membrane-targeting domain of SNAP-25 (residues 85-120) is similar to
that of endogenous SNAP-25.
A Conserved Sequence of Five Amino Acids Is Necessary for Efficient
Localization and Palmitoylation of the Membrane-targeting
Domain--
Analysis of the deletion mutants revealed that residues
116-120 are required for localization of SNAP-25 at the plasma
membrane. Alignment of the sequences of SNAP-25 family members with
residues 85-120 of SNAP-25b (Fig. 5)
revealed that three of the five residues are absolutely conserved in
all of the sequences. To determine if the conserved residues are
important for membrane targeting, we made alanine substitutions at
Gln116, Pro117, and Arg119 in
85-120/GFP (85-120 QPR/GFP). As shown in Fig.
6, 85-120 QPR/GFP was poorly localized
at the plasma membrane (center panel). Although some plasma
membrane fluorescence was evident, there was prominent cytoplasmic
staining when compared with the intact membrane-targeting domain
(left panel). However, mutation of the three residues did not inhibit localization as severely as did deletion of all five residues (right panel).
We performed subcellular fractionation studies to confirm the ability
of residues 85-120 to facilitate membrane interactions. We analyzed
the distribution of 85-120/GFP, 1-115/GFP, and 85-120 QPR/GFP in
particulate and soluble fractions of transfected NG108 cells.
85-120/GFP was found predominately in the P100 (membrane) fraction,
whereas both 85-120 QPR/GFP and 1-115/GFP were predominately cytosolic (Fig. 7). The results of the
subcellular fractionation confirm the localization depicted by
fluorescence microscopy.
Palmitoylation of the mutated proteins correlated with membrane
association. The amount of [3H]palmitate incorporated
into 85-120 QPR/GFP and 1-115/GFP was substantially reduced compared
with intact 85-120/GFP (Fig. 8). Although the cysteine residues are maintained in both 85-120 QPR/GFP and 1-115/GFP, these data suggest that the five-amino acid motif QPARV
facilitates palmitoylation of the protein, thereby promoting membrane
association of SNAP-25.
In this study, we mapped the minimal region of SNAP-25 that
confers targeting specifically to the plasma membrane to residues 85-120. The membrane-targeting domain represents two-thirds of the
interhelical loop that connects the N- and C-terminal Residues 85-120 of SNAP-25 constitute a membrane-targeting domain with
unique characteristics. Plasma membrane association not only is
dependent on the stretch of palmitoylated cysteines contained within
the first eight amino acids of the targeting sequence (Ref. 18 and this
study), but also requires an additional 27 amino acids. This
distinguishes SNAP-25 from other lipid-modified proteins in which the
boundary of the membrane-targeting sequence is in close proximity to
lipid-modified amino acids. Targeting information for non-receptor
tyrosine kinases p59fyn and p56lck is contained in
their 10 N-terminal residues (26, 27). This region includes the
myristoylated glycine at position 2 and two nearby cysteines modified
by palmitate. Membrane association of p59fyn is maintained when
this sequence is replaced with the first 10 amino acids of GAP-43,
which includes two palmitoylated cysteines (14).
There are two distinct regions of highly conserved sequence across
species that can be observed when the predicted membrane-targeting domains of SNAP-25 family members are aligned (Fig. 5). These regions
coincide with the N- and C-terminal boundaries of the membrane-targeting domain. The first is the cysteine-rich region (residues 85-92). The second is a five-amino acid motif
(QPXR(V/I)) at the C terminus of the domain. Mutation of
three of the five amino acids (Gln, Pro, and Arg) to alanine severely
compromised localization of the membrane-targeting domain and
significantly decreased palmitate incorporation. SNAP-25 is synthesized
as a soluble protein, but must associate with a membrane-bound
palmitoyltransferase to become fatty acylated (15). Thus, there must be
a mechanism to provide at least transient interaction of SNAP-25 with
membranes to permit palmitoylation. We speculate that the C-terminal
QPARV motif permits binding of SNAP-25 to a membrane protein, thereby facilitating recognition of SNAP-25 by a membrane-bound
palmitoyltransferase (Fig. 9). It is possible that the same molecule
displays both functions, i.e. binding to the
membrane-targeting domain and palmitoylation.
A requirement for membrane association prior to palmitoylation has been
observed for a number of palmitoylated proteins. Modification of
proteins at tandem lipidation motifs occurs sequentially (reviewed in
Ref. 13). Palmitoylation of non-receptor tyrosine kinases is dependent
upon prior myristoylation. Similarly, prenylation is a
prerequisite for palmitoylation of Ha-Ras and N-Ras. These proteins are
modified with an N-myristoyl or farnesyl group in the
cytoplasm. The addition of the first lipid provides a low affinity
interaction with membranes that appears to permit contact with the
palmitoyltransferase. The addition of the second lipid significantly
increases membrane affinity, resulting in essentially permanent
association of the protein on the membrane where it was
modified with palmitate (28). G-protein Our finding that the interhelical domain of SNAP-25 confers membrane
localization raises the possibility that this region functions
similarly in other SNAP-25 family members. Morphological analysis of
the yeast exocytic complex confirms that Sec9p, a yeast SNAP-25
homolog, forms a four-helix bundle with the yeast syntaxin homolog Sso1
or Sso2 and synaptobrevin homolog Snc1 or Snc2 (31). Plasma membrane
localization of Sec9p in vivo does not require Sso1/2 (32),
suggesting that its membrane localization may be independent of SNARE
interactions. Sec9p lacks palmitoylation sites; thus it must associate
with membranes through mechanisms other than fatty acylation.
SNAP-23 and syndet are ubiquitously expressed isoforms of SNAP-25 that
are localized at the plasma membrane (33, 34). In contrast, a newly
identified family member, SNAP-29, is localized predominantly on
intracellular membranes when transfected into normal rat kidney cells
(35). Its distribution overlaps with that of markers for the Golgi, the
trans-Golgi network, and endosomal compartments. Sequences
directing membrane attachment of SNAP-23 and SNAP-29 have not been well
characterized. The cysteine-rich sequence within the membrane-targeting
domain of SNAP-25 is conserved in SNAP-23 and syndet as well as the
QPXR(V/I) motif (Fig. 5). The sequence similarity strongly
suggests conservation of the membrane-targeting function of the
interhelical domain. Baldini and co-workers (36) have recently reported
that plasma membrane localization of syndet requires the cysteine-rich
domain (36). Interestingly, residues 89-101 (RTKNFESGKNYKA)
of syndet are dispensable for plasma membrane localization (36). These
residues immediately follow the cysteine stretch in syndet and
correspond to a part of the membrane-targeting domain of SNAP-25 that
is poorly conserved among family members (Fig. 5).
The putative interhelical domain of SNAP-29 lacks palmitoylation sites
and has no other sequence similarity to SNAP-25, SNAP-23, and syndet.
However, a significant fraction of SNAP-29 behaves as an integral
membrane protein when expressed in COS cells. It has been suggested
that SNAP-29 is recruited to membranes through interactions with
different syntaxins and vesicle-associated membrane proteins, bypassing
the need for a strict membrane-anchoring motif and allowing it to
function in a variety of compartments (35). We have demonstrated that
SNAP-25 can be targeted to the plasma membrane independently of its
interactions with SNARE proteins. However, this does not exclude the
possibility that a SNARE-dependent mechanism also exists.
It will be important to define the mechanisms of membrane association
of SNAP-25 family members to test whether the interhelical domain has a
general role in membrane localization or serves a specialized function
for neuronal SNAP-25.
We thank Dr. Michael Wilson for providing the
SNAP-25b cDNA, Drs. Phyllis Hanson and Susan Wente for helpful
suggestions, and members of our laboratory for comments on the manuscript.
*
This work was supported by the McDonnell Center for Cellular
and Molecular Neurobiology at Washington University School of Medicine
and United States Public Health Service Grant GM51466.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
S. Gonzalo and M. E. Linder, unpublished results.
The abbreviations used are:
BFA, brefeldin A;
GFP, green fluorescent protein;
PCR, polymerase chain reaction.
SNAP-25 Is Targeted to the Plasma Membrane through a Novel
Membrane-binding Domain*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helices that SNAP-25 contributes to the four-helix bundle of the
synaptic SNARE complex. Our results demonstrate that residues 85-120
of SNAP-25 represent a protein module that is physically and
functionally separable from the SNARE complex-forming domains.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-subunits that are fatty
acylated with both amide-linked myristate and thioester-linked
palmitate and certain isoforms of Ras that are prenylated and palmitoylated.
, is sensitive to agents such as
BFA1 that disrupt the
secretory pathway (15). These results are consistent with at least two
pathways for targeting lipid-modified proteins to the plasma membrane.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (26K):
[in a new window]
Fig. 1.
Schematic representation of fusion proteins
used in this study. The top diagram represents full-length
SNAP-25. Hatched bars indicate
-helical domains composed
of sets of heptad repeats (H1, H2, and
H3). The cysteine-rich domain between residues 85 and 92 is
shown in all constructs. The numbers on the fusion proteins
indicate the amino acids of the human SNAP-25b isoform that were fused
to GFP.

View larger version (45K):
[in a new window]
Fig. 2.
SNAP-25/GFP fusion protein (GFP/1-206) is
targeted to the plasma membrane. NG108 cells transfected with GFP
or full-length SNAP-25 fused to GFP (GFP/1-206) were fixed and
visualized by fluorescence microscopy (A) or lysed and
analyzed by immunoblotting with an anti-GFP monoclonal antibody and
detected using enhanced chemiluminescence (B).
-helices that are involved in intermolecular
coiled-coils (4). We began the analysis by deleting the C-terminal set
of heptad repeats (H3 in Fig. 1) and expressed a protein
with the N-terminal 142 amino acids of SNAP-25 fused to GFP. As shown
in Fig. 3a, amino acids 1-142
of SNAP-25 were able to target GFP to the plasma membrane, indicating
that the C-terminal portion of the protein is not required for proper
targeting. As for the full-length protein (18, 19), plasma membrane
localization of the 1-142/GFP chimera depended on the four
palmitoylated cysteine residues since a mutant chimeric protein in
which the four cysteines were mutated to alanines had a cytoplasmic
distribution (Fig. 3b).

View larger version (125K):
[in a new window]
Fig. 3.
Subcellular distribution of deletion mutants
of SNAP-25/GFP. NG108 cells were transfected with SNAP-25 deletion
mutants and visualized by fluorescence microscopy. Note that residues
85-120 constitute the minimal domain of SNAP-25 necessary and
sufficient to target GFP to membranes (i).

View larger version (62K):
[in a new window]
Fig. 4.
Palmitoylation of SNAP-25/GFP fusion proteins
is sensitive to BFA. NG108 cells transfected with GFP/1-206 or
the membrane-targeting domain 85-120/GFP were incubated with
[3H]palmitate ([3H]palm;
lanes 3, 4, 7, and 8) or
[35S]methionine
([35S]meth; lanes 1,
2, 5, and 6) for 90 min in the
presence or absence of 10 µg/ml BFA. The incorporation of radiolabel
into the immunoprecipitated proteins was assessed by SDS-polyacrylamide
gel electrophoresis and fluorography. Note how palmitoylation of both
chimeric proteins was sensitive to treatment with BFA. Protein
expression, however, was not affected by BFA treatment.
![]()
View larger version (20K):
[in a new window]
Fig. 5.
Sequence alignment of SNAP-25 family
members. Sequences corresponding to the membrane-targeting domain
(residues 85-120) of the SNAP-25b isoform from SNAP-25 family members
were aligned using the Clustal method (DNASTAR, Inc.). Residues
conserved in at least six of eight sequences are boxed.
GenBankTM accession numbers for the sequences are as
follows: mouse, M22012; goldfish, 548945; Torpedo, L22020;
Drosophila, L22021; Caenorhabditis elegans,
3880712; human SNAP-23, U55936; and mouse syndet, U73143.

View larger version (77K):
[in a new window]
Fig. 6.
Plasma membrane localization of the
interhelical domain of SNAP-25 requires amino acids 116-120.
NG108 cells were transfected with 85-120/GFP (left panel),
85-120 QPR/GFP (center panel), or 1-115/GFP (right
panel) and visualized by confocal microscopy. Deletion of residues
116-120 or mutation of three of the five residues results in
significant reduction of plasma membrane staining of SNAP-25 fusion
protein. WT, wild type.

View larger version (44K):
[in a new window]
Fig. 7.
Residues 116-120 of SNAP-25 are important
for membrane association. Shown are the results from immunoblot
analysis of subcellular fractions of NG108 cells expressing 85-120/GFP
(left bars), 85-120 QPR/GFP (center bars), or
1-115/GFP (right bars). The distribution of SNAP-25 fusion
protein in P100 (dark bars) and S100 (light bars)
fractions was quantitated using a PhosphorImager. Data are expressed as
the mean ± S.D. of three (85-120 QPR/GFP and 1-115/GFP) or four
(85-120/GFP) experiments. A representative experiment is shown below
the graph. Not shown are the P1 fractions (low speed pellet) that
contained approximately one-fourth of the immunoreactivity for all
constructs. Only the intact interhelical domain of SNAP-25 (residues
85-120) was found predominately in the particulate fraction.

View larger version (46K):
[in a new window]
Fig. 8.
Residues 116-120 facilitate palmitoylation
of the interhelical domain of SNAP-25. SNAP-25 fusion proteins
were analyzed for incorporation of [3H]palmitate
([3H]palm; left panel) or
[35S]methionine
([35S]meth; right panel) as
described under "Experimental Procedures." 85-120/GFP labeled with
[35S]methionine migrates as a doublet because
palmitoylation of the protein results in a shift in electrophoretic
mobility (15). Deletion or mutation of residues 116-120 significantly
reduced incorporation of [3H]palmitate into the
interhelical domain of SNAP-25. WT, wild type.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helices of
SNAP-25 in the SNARE complex (Fig. 9). We
have established that an important function of the interhelical loop is
to localize SNAP-25 at the plasma membrane. This function appears to be
independent of SNARE interactions since removal of the regions of
SNAP-25 that form coiled-coils with syntaxin and synaptobrevin did not interfere with proper targeting of SNAP-25 fusion proteins. It is
noteworthy that the membrane-targeting domain coincides almost exactly
with the protease-sensitive region of SNAP-25 (residues 83-120) in the
SNARE complex. The sensitivity of SNAP-25 residues 83-120 in the
complex to proteases (11, 12) and the fact that this domain had to be
deleted to obtain crystals of the core SNARE complex suggest that it
may be disordered in vitro. However, it seems probable that
interactions with the bilayer or with other proteins will result in a
more ordered structure of the membrane-binding domain.

View larger version (43K):
[in a new window]
Fig. 9.
Model of membrane interactions of
SNAP-25. The N- and C-terminal
-helices of SNAP-25 that
interact with syntaxin and synaptobrevin are shown as dark-gray
coils. The membrane-targeting domain (residues 85-120) is shown
binding to a hypothetical membrane protein (light-gray
oval). Residues 116-120 are shown as a cylinder at the
end of the membrane-targeting domain. Palmitate groups attached to
cysteines 85, 88, 90, and 92 are depicted inserting into the lipid
bilayer. The loop (residues 121-137) connecting the C terminus of the
membrane-targeting domain with the second
-helix is shown in
black. (adapted with permission from Sutton et
al. (4)).
-subunits that are
dually modified with myristate and palmitate exhibit a similar interdependence of lipid modifications. However, the failure
to palmitoylate myristoylation-defective G
subunits can be
overcome by coexpressing G-protein 
-subunits (29, 30). Thus,
there is precedent for interaction of a palmitoyltransferase substrate with a membrane protein other than a palmitoyltransferase prior to its modification.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Cell Biology
and Physiology, Washington University School of Medicine, 660 S. Euclid
Ave., P. O. Box 8228, St. Louis, MO 63110. Tel.: 314-362-6040; Fax:
314-362-7463; E-mail: mlinder@cellbio.wustl.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Rothman, J.
(1994)
Nature
372,
55-63[CrossRef][Medline]
[Order article via Infotrieve]
2.
Bennett, M. K.,
and Scheller, R. H.
(1994)
Annu. Rev. Biochem.
63,
63-100[CrossRef][Medline]
[Order article via Infotrieve]
3.
Sudhof, T.
(1995)
Nature
375,
645-653[CrossRef][Medline]
[Order article via Infotrieve]
4.
Sutton, R. B.,
Fasshauer, D.,
Jahn, R.,
and Brunger, A. T.
(1998)
Nature
395,
347-353[CrossRef][Medline]
[Order article via Infotrieve]
5.
Poirier, M. A.,
Xiao, W.,
Macosko, J. C.,
Chan, C.,
Shin, Y.-K.,
and Bennett, M. K.
(1998)
Nat. Struct. Biol.
5,
765-769[CrossRef][Medline]
[Order article via Infotrieve]
6.
Hanson, P. I.,
Roth, R.,
Morisaki, H.,
Jahn, R.,
and Heuser, J. E.
(1997)
Cell
90,
523-535[CrossRef][Medline]
[Order article via Infotrieve]
7.
Lin, R. C.,
and Scheller, R. H.
(1997)
Neuron
19,
1087-1094[CrossRef][Medline]
[Order article via Infotrieve]
8.
Weber, T.,
Zemelman, B. V.,
McNew, J. A.,
Westermann, B.,
Gmachl, M.,
Parlati, F.,
Sollner, T. H.,
and Rothman, J. E.
(1998)
Cell
92,
759-772[CrossRef][Medline]
[Order article via Infotrieve]
9.
Ungermann, C.,
Sato, K.,
and Wickner, W.
(1998)
Nature
396,
543-548[CrossRef][Medline]
[Order article via Infotrieve]
10.
Hess, D. T.,
Slater, T. M.,
Wilson, M. C.,
and Skene, J. H. P.
(1992)
J. Neurosci.
12,
4634-4641[Abstract]
11.
Fasshauer, D.,
Eliason, W. K.,
Brunger, A. T.,
and Jahn, R.
(1998)
Biochemistry
37,
10354-10362[CrossRef][Medline]
[Order article via Infotrieve]
12.
Poirier, M. A.,
Hao, J. C.,
Malkus, P. N.,
Chan, C.,
Moore, M. F.,
King, D. S.,
and Bennet, M. K.
(1998)
J. Biol. Chem.
273,
11370-11377 13.
Dunphy, J. T.,
and Linder, M. E.
(1998)
Biochim. Biophys. Acta
1436,
245-261[Medline]
[Order article via Infotrieve]
14.
van't Hof, W.,
and Resh, M. D.
(1997)
J. Cell Biol.
136,
1023-1035 15.
Gonzalo, S.,
and Linder, M. E.
(1998)
Mol. Biol. Cell
9,
585-597 16.
Di Paolo, G.,
Lutjens, R.,
Pellier, V.,
Stimpson, S. A.,
Beuchat, M.-H.,
Catsicas, S.,
and Grenningloh, G.
(1997)
J. Biol. Chem.
272,
5175-5182 17.
Liu, Y.,
Fisher, D. A.,
and Storm, D. R.
(1993)
Biochemistry
32,
10714-10719[CrossRef][Medline]
[Order article via Infotrieve]
18.
Lane, S. R.,
and Liu, Y.
(1997)
J. Neurochem.
69,
1864-1869[Medline]
[Order article via Infotrieve]
19.
Veit, M.,
Sollner, T. H.,
and Rothman, J. E.
(1996)
FEBS Lett.
385,
119-123[CrossRef][Medline]
[Order article via Infotrieve]
20.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
21.
Oyler, G. A.,
Higgins, G. A.,
Hart, R. A.,
Battenberg, E.,
Billingsley, M.,
Bloom, F. E.,
and Wilson, M. C.
(1989)
J. Cell Biol.
89,
3039-3052
22.
Oyler, G.,
Polli, J.,
Higgins, G.,
Wilson, M.,
and Billingsley, M.
(1992)
Dev. Brain Res.
65,
133-146[CrossRef][Medline]
[Order article via Infotrieve]
23.
Chapman, E. R.,
An, S.,
Barton, N.,
and Jahn, R.
(1994)
J. Biol. Chem.
269,
27427-27432 24.
Bark, I. C.
(1993)
J. Mol. Biol.
233,
67-76[CrossRef][Medline]
[Order article via Infotrieve]
25.
Bark, I.,
and Wilson, M.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
4621-4624 26.
Zlatkine, P.,
Mehul, B.,
and Magee, A. I.
(1997)
J. Cell Sci.
110,
673-679[Abstract]
27.
Wolven, A.,
Okamura, H.,
Rosenblatt, Y.,
and Resh, M. D.
(1997)
Mol. Biol. Cell
8,
1159-1173[Abstract]
28.
Shahinian, S.,
and Silvius, J. R.
(1995)
Biochemistry
34,
3813-3822[CrossRef][Medline]
[Order article via Infotrieve]
29.
Morales, J.,
Fishburn, C. S.,
Wilson, P. T.,
and Bourne, H. R.
(1998)
Mol. Biol. Cell
9,
1-14 30.
Degtyarev, M. Y.,
Spiegel, A. M.,
and Jones, T. L. Z.
(1994)
J. Biol. Chem.
269,
30898-30903 31.
Katz, L.,
Hanson, P. I.,
Heuser, J. E.,
and Brennwald, P.
(1998)
EMBO J.
17,
6200-6209[CrossRef][Medline]
[Order article via Infotrieve]
32.
Rossi, G.,
Salminen, A.,
Rice, L. M.,
Brunger, A. T.,
and Brennwald, P.
(1997)
J. Biol. Chem.
272,
16610-16617 33.
Ravichandran, V.,
Chawla, A.,
and Roche, P. A.
(1996)
J. Biol. Chem.
271,
13300-13303 34.
Wang, G.,
Witkin, J. W.,
Hao, G.,
Bankaitis, V. A.,
Scherer, P. E.,
and Baldini, G.
(1997)
J. Cell Sci.
110,
505-513[Abstract]
35.
Steegmaier, M.,
Yang, B.,
Yoo, J.-S.,
Huang, B.,
Shen, M., Yu, S.,
Luo, Y.,
and Scheller, R. H.
(1998)
J. Biol. Chem.
273,
34171-34179 36.
Koticha, D. K.,
Huddleston, S. J.,
Witkin, J. W.,
and Baldini, G.
(1999)
J. Biol. Chem.
274,
9053-9060
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Nagy, I. Milosevic, R. Mohrmann, K. Wiederhold, A. M. Walter, and J. B. Sorensen The SNAP-25 Linker as an Adaptation Toward Fast Exocytosis Mol. Biol. Cell, September 1, 2008; 19(9): 3769 - 3781. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Medine, C. Rickman, L. H. Chamberlain, and R. R. Duncan Munc18-1 prevents the formation of ectopic SNARE complexes in living cells J. Cell Sci., December 15, 2007; 120(24): 4407 - 4415. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, N. R. Chintagari, D. Gou, L. Su, and L. Liu Physical and Functional Interactions of SNAP-23 with Annexin A2 Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 467 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Flaumenhaft, N. Rozenvayn, D. Feng, and A. M. Dvorak SNAP-23 and syntaxin-2 localize to the extracellular surface of the platelet plasma membrane Blood, September 1, 2007; 110(5): 1492 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Sim, J. R. Dilks, and R. Flaumenhaft Platelets Possess and Require an Active Protein Palmitoylation Pathway for Agonist-Mediated Activation and In Vivo Thrombus Formation Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1478 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sanderfoot Increases in the Number of SNARE Genes Parallels the Rise of Multicellularity among the Green Plants Plant Physiology, May 1, 2007; 144(1): 6 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Aikawa, X. Xia, and T. F.J. Martin SNAP25, but Not Syntaxin 1A, Recycles via an ARF6-regulated Pathway in Neuroendocrine Cells Mol. Biol. Cell, February 1, 2006; 17(2): 711 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nagy, I. Milosevic, D. Fasshauer, E. M. Muller, B. L. de Groot, T. Lang, M. C. Wilson, and J. B. Sorensen Alternative Splicing of SNAP-25 Regulates Secretion through Nonconservative Substitutions in the SNARE Domain Mol. Biol. Cell, December 1, 2005; 16(12): 5675 - 5685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Salaun, G. W. Gould, and L. H. Chamberlain Lipid Raft Association of SNARE Proteins Regulates Exocytosis in PC12 Cells J. Biol. Chem., May 20, 2005; 280(20): 19449 - 19453. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Salaun, G. W. Gould, and L. H. Chamberlain The SNARE Proteins SNAP-25 and SNAP-23 Display Different Affinities for Lipid Rafts in PC12 Cells: REGULATION BY DISTINCT CYSTEINE-RICH DOMAINS J. Biol. Chem., January 14, 2005; 280(2): 1236 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kang, R. Swayze, M. F. Lise, K. Gerrow, A. Mullard, W. G. Honer, and A. El-Husseini Presynaptic Trafficking of Synaptotagmin I Is Regulated by Protein Palmitoylation J. Biol. Chem., November 26, 2004; 279(48): 50524 - 50536. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. An and W. Almers Tracking SNARE Complex Formation in Live Endocrine Cells Science, November 5, 2004; 306(5698): 1042 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dong, W. H. Tepp, E. A. Johnson, and E. R. Chapman Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells PNAS, October 12, 2004; 101(41): 14701 - 14706. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bark, F. P. Bellinger, A. Kaushal, J. R. Mathews, L. D. Partridge, and M. C. Wilson Developmentally Regulated Switch in Alternatively Spliced SNAP-25 Isoforms Alters Facilitation of Synaptic Transmission J. Neurosci., October 6, 2004; 24(40): 8796 - 8805. [Abstract] [Full Text] [PDF] |